期刊文献+
共找到2,577篇文章
< 1 2 129 >
每页显示 20 50 100
小鼠Retn基因siRNAs的设计及其稳定表达载体的构建 被引量:1
1
作者 李雅慧 黎怀星 +3 位作者 吴丹 施柯 蔡东联 孙树汉 《第二军医大学学报》 CAS CSCD 北大核心 2004年第2期136-139,共4页
目的 :设计小鼠 Retn基因特异性的 si RNAs,并构建一系列能在哺乳动物细胞内稳定表达这些 si RNAs的表达质粒 ,以便为在体外研究 Retn基因的功能打下基础。 方法 :(1 )设计并合成小鼠 Retn基因特异性的一组寡核苷酸片段 ,并克隆到 p Sil... 目的 :设计小鼠 Retn基因特异性的 si RNAs,并构建一系列能在哺乳动物细胞内稳定表达这些 si RNAs的表达质粒 ,以便为在体外研究 Retn基因的功能打下基础。 方法 :(1 )设计并合成小鼠 Retn基因特异性的一组寡核苷酸片段 ,并克隆到 p Silencer EM 1 .0 - N eo载体 ;(2 )用电穿孔转染和 G4 1 8筛选等方法建立能稳定表达相应 si RNAs的一组 3T3- L1细胞克隆 ;(3)诱导细胞分化为脂肪细胞 ,并用 RT- PCR分析这些脂肪细胞内 Retn基因的 m RNA水平。 结果 :设计并构建了 4个小鼠Retn基因特异性的 si RNAs表达质粒 ,并证明其中的 2种质粒能在脂肪细胞内稳定表达相应的 si RNAs,显著地抑制了这些脂肪细胞内 Retn基因的 m RNA水平。 结论 :本研究设计并构建出的小鼠 Retn基因特异性的 si RNAs表达载体 ,所表达的 si R-NAs具有较强的 RNA干涉功能 ,为 展开更多
关键词 小鼠 Retn基因 sirnas 设计 载体 基因表达 脂肪细胞
下载PDF
针对HBVS基因发夹状siRNAs表达载体的构建及其在HepG2215细胞中对HBV基因表达的抑制作用 被引量:1
2
作者 范旭 何升松 《实用肝脏病杂志》 CAS 2006年第4期203-205,共3页
目的探讨通过载体在体外培养的细胞中表达发夹状siRNAs对HBV基因表达的抑制作用。方法构建表达针对HBV S基因mRNA的发夹状siRNAs的质粒pSilencer 2.1-U6-S,并与ayw亚型HBV全基因组表达质粒共转染体外培养的HepG2215细胞,用半定量RT-PCR... 目的探讨通过载体在体外培养的细胞中表达发夹状siRNAs对HBV基因表达的抑制作用。方法构建表达针对HBV S基因mRNA的发夹状siRNAs的质粒pSilencer 2.1-U6-S,并与ayw亚型HBV全基因组表达质粒共转染体外培养的HepG2215细胞,用半定量RT-PCR分析目标mRNA表达丰度的变化,用ELISA法观察HBsAg表达的变化。结果siRNA处理组细胞上清中HbsAg和HBeAg含量分别比空白对照组降低了63.4%和68.0%,细胞中的2.1kb的信使RNA降低了75.2%。结论siRNA在体外培养的细胞中能有效地抑制HBV基因的表达。 展开更多
关键词 乙型肝炎病毒 发夹状sirnas 表达载体 共转染
下载PDF
日本血吸虫内源性siRNAs的研究 被引量:1
3
作者 郝力力 李锐 郑威 《安徽农学通报》 2011年第15期71-73,共3页
为鉴定日本血吸虫体内是否存在内源性siRNA,采用生物信息学方法对成虫和14d童虫Solexa测序后得到的序列进行了分析,发现成虫和童虫中确实存在内源性siRNAs,而且所占比例和m iRNAs相当,说明内源性siRNAs可能对日本血吸虫基因转录起着重... 为鉴定日本血吸虫体内是否存在内源性siRNA,采用生物信息学方法对成虫和14d童虫Solexa测序后得到的序列进行了分析,发现成虫和童虫中确实存在内源性siRNAs,而且所占比例和m iRNAs相当,说明内源性siRNAs可能对日本血吸虫基因转录起着重要调控作用。 展开更多
关键词 日本血吸虫 sirnas 转座子
下载PDF
D-siRNAs抑制A549细胞COX-2表达
4
作者 罗红 胡冬煦 陈平 《基础医学与临床》 CSCD 北大核心 2008年第7期707-712,共6页
目的长片段双链COX-2RNA(dsRNAs)在体外经Dicer酶消化获得小RNA(D-siRNAs)抑制A549细胞COX-2的表达。方法(1)IL-1β5 g/L干预A549细胞,Western blot法观察其COX-2蛋白表达的时间依赖性。(2)Trizol法抽提A549细胞总RNA,RT-PCR扩增COX-2... 目的长片段双链COX-2RNA(dsRNAs)在体外经Dicer酶消化获得小RNA(D-siRNAs)抑制A549细胞COX-2的表达。方法(1)IL-1β5 g/L干预A549细胞,Western blot法观察其COX-2蛋白表达的时间依赖性。(2)Trizol法抽提A549细胞总RNA,RT-PCR扩增COX-2基因。(3)设计两端带T7 promoter,SP6 promoter的COX-2cDNA的PCR引物,通过PCR方法,获得两端带T7及SP6 promoter的COX-2DNA。(4)用RiboMAX Large Scale RNA Produc-tion Systems-SP6 and T7试剂盒体外将COX-2DNA转录为RNA。(5)长片段COX-2RNA经Dicer酶消化为小RNA(D-siRNAs)。(6)用TransMessenger Transfection Reagent将D-siRNAs转染A549细胞。(7)COX-2mRNA表达用RT-PCR检测,细胞培养上清液中PGE2含量用ELISA测定。结果(1)IL-1β干预A549细胞9 h后COX-2表达到高峰。(2)在体外,长片段COX-2dsRNAs经Dicer酶消化获得D-siRNAs。(3)D-siRNAs可有效抑制A549细胞COX-2的表达并降低PGE2的分泌。结论长片段双链COX-2RNA(dsRNAs)在体外经Dicer酶消化获得小RNA可有效抑制A549细胞COX-2的表达。 展开更多
关键词 环氧化酶2 A549细胞 D—sirnas RNA干扰
下载PDF
siRNAs在基因治疗中的应用 被引量:1
5
作者 胡迎宾 李定国 《世界华人消化杂志》 CAS 北大核心 2005年第16期2040-2042,共3页
利用小分子物质特异性沉默基因表达是一种有效的治疗手段,许多研究正在利用这些小分子物质的作用而创造出新的治疗性药物.小干扰RNAs(smallinterferingRNAs,siRNAs)最有可能成为这类药物中的新成员.本文将从siRNAs的沉默机制、基因沉默... 利用小分子物质特异性沉默基因表达是一种有效的治疗手段,许多研究正在利用这些小分子物质的作用而创造出新的治疗性药物.小干扰RNAs(smallinterferingRNAs,siRNAs)最有可能成为这类药物中的新成员.本文将从siRNAs的沉默机制、基因沉默效率、表达载体,siRNAs在活体内的应用以及作为可能的治疗性药物等方面,探讨其应用于临床治疗的巨大潜能. 展开更多
关键词 sirnas 基因治疗 小分子物质 基因沉默 类药物 治疗手段 基因表达 表达载体 临床治疗
下载PDF
PSD95 Gene Specific siRNAs Attenuate Neuropathic Pain through Modulating Neuron Sensibility and Postsynaptic CaMKIIα Phosphorylation 被引量:1
6
作者 Le Shen Xu Li Wen Chen Li Xu Wei Liu Xue-rong Yu Yu-guang Huang 《Chinese Medical Sciences Journal》 CAS CSCD 2011年第4期201-207,共7页
Objective To observe the effects of PSD95 gene specific siRNAs on neuropathic pain relief, neuron viability, and postsynaptic calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation in vitro and in... Objective To observe the effects of PSD95 gene specific siRNAs on neuropathic pain relief, neuron viability, and postsynaptic calcium/calmodulin-dependent protein kinase IIα (CaMKIIα) phosphorylation in vitro and in vivo. Methods Gene-specific siRNAs of rat PSD95 were synthesized chemically for transfection. Adult male Sprague-Dawley (SD) rats were randomly divided into 3 groups: nave group (n=6), sham group (n=6), and sciatic nerve chronic constriction injury (CCI) group (n=24). The CCI group was further divided into 4 groups (n=6 in each group), which were pretreated with normal saline, transfection vehicle, negative control siRNAs, and PSD95 gene specific siRNAs respectively. All the subgroups received corresponding agents intrathecally for 3 days, started one day before the CCI of sciatic nerve. Both mechanical allodynia and thermal hyperalgesia were measured on post-operative day 3 and 7. PSD95 gene silenced NG108-15 cells were further stimulated by glutamate, with the cell viability and the expression/phosphorylation of CaMKIIα measured by MTT cell proliferation assay and Western blot, respectively. Results The siRNAs decreased PSD95 mRNA level significantly both in vivo and in vitro. Neuropathic pain rats pretreated with PSD95 gene specific siRNAs exhibited significant elevation in the mechanical withdrawal threshold and paw withdrawal thermal latency, without affecting the baseline nociception. PSD95 gene silencing enhanced neuronal tolerance against the glutamate excitotoxicity, meanwhile the phosphorylation of CaMKIIα Thr286 was attenuated. Conclusion Pre-emptive administration of PSD95 gene specific siRNAs may attenuate the central sensitization CaMKIIα-related signaling cascades, leading to the relief of neuropathic pain. 展开更多
关键词 PSD95 sirnas neuropathic pain glutamate excitotoxicity calcium/calmodulin- dependent protein kinase IItt
下载PDF
Novel Tuning Buttons in Tomato Fruit Ripening:miRNAs and siRNAs
7
作者 Jinhua ZUO Qing WANG +4 位作者 Zheng JU Dongyan CAO Benzhong ZHU Yunbo LUO Lipu GAO 《Agricultural Science & Technology》 CAS 2016年第7期1541-1545,共5页
Tomato has emerged as an emblematic model plants for fleshy fruit research and tomato fruit ripening is a complex and highly coordinated developmental process.The many physiology and biochemical processes associated w... Tomato has emerged as an emblematic model plants for fleshy fruit research and tomato fruit ripening is a complex and highly coordinated developmental process.The many physiology and biochemical processes associated with tomato fruit ripening require changes in the expression of hundreds to thousands of genes.Gene expression is regulated by transcriptional and post-transcriptional pathways,one of the recently discovered mechanisms in plants was small RNAs mediated gene silencing at post-transcriptional(PTGS) level.Intriguingly,several mi RNAs and endogenous si RNAs were revealed to be involved in the fruit ripening process which opened a new avenue in the field of fleshy fruit biology.This review compiled the most recent advances made in deciphering the regulation functions of mi RNAs and si RNAs in tomato fruit ripening.It also emphasized the new perspectives now possible in the small RNAs regulation research in tomato fruit ripening and senescence. 展开更多
关键词 tomato sirnas hundreds developmental emphasized Ethylene biochemical endogenous coordinated miRNAs
下载PDF
Effect of siRNAs on HSV-1 Plaque Formation and Relative Expression Levels of RR mRNA 被引量:2
8
作者 Zhe Ren Shen Li +7 位作者 Qiao-li Wang Yang-fei Xiang Yun-xia Cui Yi-fei Wang Ren-bin Qi Da-xiang Lu Shu-min Zhang Pei-zhuo Zhang 《Virologica Sinica》 SCIE CAS CSCD 2011年第1期40-46,共7页
RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed ... RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed of two distinct homodimeric subunits encoded by UL39 and UL40,respectively. In this study,we applied siRNAs targeting the UL39 and UL40 genes of HSV-1. We showed that synthetic siRNA silenced effectively and specifically UL39 and UL40 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication. 展开更多
关键词 Small interfering RNA (siRNA) Herpes simplex virus type 1 (HSV-1) Ribonucleotide reductase(RR) GENE
下载PDF
The Defined siRNAs Suppress Nanog and Sox2 Expressions in Mouse ES Cells 被引量:1
9
作者 LEI Lei DOU Lin WANG Hua-yan 《Agricultural Sciences in China》 CAS CSCD 2011年第9期1475-1481,共7页
Nanog, Oct4 and Sox2 are important transcription factors that are expressed in embryonic stem (ES) cells or embryonic carcinoma (EC) cells, but in most cases they are absent in somatic cells. These factors play a ... Nanog, Oct4 and Sox2 are important transcription factors that are expressed in embryonic stem (ES) cells or embryonic carcinoma (EC) cells, but in most cases they are absent in somatic cells. These factors play a key role to maintain embryonic stem cell self-renew and pluripotency. Down-regulation of Nanog and Sox2 gene expression can change multiple gene expression pattems and signal transduction pathways, and will initiate ES cell differentiation. This study was designed to select the efficient small interfering RNA (siRNA) fragments that inhibit Nanog and Sox2 gene expression in mouse J1 ES cells and P19 EC cells. Among synthesized siRNAs we screened out the siRNA N301 for Nanog and siRNA $720 for Sox2, which not only down- regulated of Nanog and Sox2 gene expression, but also interfered embryoid bodies formation. Our study provided the defined siRNA fragments that could be used to investigate the epigenetic function of Nanog and Sox2 genes. 展开更多
关键词 NANOG SOX2 SIRNA embryonic stem cells embryoid body
下载PDF
Potato Virus Y mRNA Expression Knockdown Mediated by siRNAs in Cultured Mammalian Cell Line
10
作者 Bushra Tabassum Idrees Ahmad Nasir Tayyab Husnain 《Virologica Sinica》 SCIE CAS CSCD 2011年第2期105-113,共9页
RNA interference(RNAi) is a powerful tool for functional gene analysis which has been successfully used to downregulate the expression levels of target genes.The goal of this research was to provide a highly robust an... RNA interference(RNAi) is a powerful tool for functional gene analysis which has been successfully used to downregulate the expression levels of target genes.The goal of this research was to provide a highly robust and concise methodology for in-vitro screening of efficient siRNAs from a bulk to be used as a tool to protect potato plants against PVY invasion.In our study,a 480bp fragment of the capsid protein gene of potato virus Y(CP-PVY) was used as a target to downregulate PVY mRNA expression in-vitro,as the CP gene interferes with viral uncoating,translation and replication.A total of six siRNAs were designed and screened through transient transfection assay and knockdown in expression of CP-PVY mRNA was calculated in CHO-k cells.CP-PVY mRNA knockdown efficiency was analyzed by RT-PCR and real-time PCR of CHO-k cells co-transfected with a CP gene construct and siRNAs.Six biological replicates were performed in this study.In our findings,one CP gene specific siRNA out of a total of six was found to be the most effective for knockdown of CP-PVY mRNA in transfected CHO-k cells by up to 80%-90%. 展开更多
关键词 RNAi Potato virus Y siRNA in-vitro Expression knockdown TRANSFECTION
下载PDF
阿霉素预处理联合GNPs-siPD-L1通过激活抗肿瘤免疫反应抑制肺癌进展 被引量:1
11
作者 姜伟华 高永山 +3 位作者 王贵刚 杨燕君 董跃华 张振明 《中国老年学杂志》 CAS 北大核心 2024年第5期1173-1178,共6页
目的 探讨包含程序性细胞死亡蛋白配体(PD-L)1小干扰RNA(siRNA)的金纳米粒(GNPs-siPD-L1)联合阿霉素预处理通过激活抗肿瘤免疫-反应抑制肺癌进展。方法 通过透射电镜观测GNPs-siPD-L1的外观形态;利用Western印迹检测肺癌细胞中的PD-L1表... 目的 探讨包含程序性细胞死亡蛋白配体(PD-L)1小干扰RNA(siRNA)的金纳米粒(GNPs-siPD-L1)联合阿霉素预处理通过激活抗肿瘤免疫-反应抑制肺癌进展。方法 通过透射电镜观测GNPs-siPD-L1的外观形态;利用Western印迹检测肺癌细胞中的PD-L1表达;使用流式细胞术检测肺癌细胞对GNPs-siPD-L1的摄取能力;通过小鼠移植瘤模型验证GNPs-siPD-L1的体内抑瘤能力;免疫组化法检测肿瘤组织中T细胞的浸润情况;流式细胞术及TUNEL染色检测肿瘤组织中细胞凋亡情况。结果 构建的GNPs-siPD-L1粒径均一,且可以明显增加肺癌细胞对PD-L1 siRNA的摄取(P<0.001),明显降低PD-L1表达(P<0.05);GNPs-siPD-L1联合阿霉素预处理可以明显抑制肺癌细胞在小鼠体内生长(P<0.001);同时,GNPs-siPD-L1联合阿霉素预处理还可以显著增加肿瘤组织中T细胞浸润(P<0.001),明显增加肿瘤组织中的细胞凋亡(P<0.001)。结论 低剂量阿霉素预处理联合GNPs-siPD-L1可以激发抗肿瘤免疫反应,抑制小鼠肺癌进展。 展开更多
关键词 肺癌 免疫治疗 程序性细胞死亡配体(PD-L)1 小干扰RNA(siRNA) 阿霉素
下载PDF
下调上皮内膜蛋白1抑制胶质母细胞瘤恶性生物学行为的实验研究
12
作者 王君祥 龚铭杰 +1 位作者 孙成法 邵琦 《中国医药科学》 2024年第13期12-15,共4页
目的研究下调上皮内膜蛋白1(EMP1)对胶质母细胞瘤U251与U87细胞系增殖、侵袭、迁移、凋亡及U87细胞系荷瘤小鼠肿瘤体积及免疫组化指标的影响。方法采用siRNA干扰技术下调胶质母细胞瘤细胞系U87与U251中EMP1的表达。RT-qPCR和Western blo... 目的研究下调上皮内膜蛋白1(EMP1)对胶质母细胞瘤U251与U87细胞系增殖、侵袭、迁移、凋亡及U87细胞系荷瘤小鼠肿瘤体积及免疫组化指标的影响。方法采用siRNA干扰技术下调胶质母细胞瘤细胞系U87与U251中EMP1的表达。RT-qPCR和Western blot检测EMP1mRNA和蛋白的表达;CCK8和Transwell实验检测EMP1下调后肿瘤细胞增殖迁移及侵袭能力;流式细胞术检测EMP1下调后肿瘤细胞凋亡表达水平;构建U87细胞系裸鼠荷瘤模型,免疫组化法检测Ki-67和MMP2的表达。结果RT-qPCR和Western blot结果显示siRNA-EMP1导致EMP1的表达降低(P<0.05),CCK8和Transewll实验显示下调EMP1后肿瘤细胞的增殖、迁移及侵袭能力被显著抑制(P<0.05);流式细胞术结果显示下调EMP1后肿瘤细胞的凋亡能力明显增强(P<0.05);U87细胞系裸鼠荷瘤模型中下调EMP1后肿瘤细胞生长延缓,Ki-67及MMP2的表达降低。结论EMP1的表达下调可以抑制胶质母细胞瘤的增殖、迁移及侵袭,促进凋亡,延缓荷瘤小鼠肿瘤的生长与侵袭,从而抑制胶质母细胞瘤的恶性生物学行为。 展开更多
关键词 上皮内膜蛋白1 胶质母细胞瘤 siRNA干扰技术 恶性生物学行为
下载PDF
CKIP-1 siRNA影响膝关节骨性关节炎进展的动物实验研究
13
作者 戴章生 《齐齐哈尔医学院学报》 2024年第17期1601-1605,共5页
目的 探讨CKIP-1 siRNA对膝关节骨性关节炎进展的影响研究。方法 建立大鼠膝关节骨关节炎模型,选取其中一只分离培养实验大鼠骨髓间充质干细胞,分为空白组、阴性对照组和不同浓度的Ckip-1 siRNA组(10 pmol/ml、20 pmol/ml和50 pmol/ml)... 目的 探讨CKIP-1 siRNA对膝关节骨性关节炎进展的影响研究。方法 建立大鼠膝关节骨关节炎模型,选取其中一只分离培养实验大鼠骨髓间充质干细胞,分为空白组、阴性对照组和不同浓度的Ckip-1 siRNA组(10 pmol/ml、20 pmol/ml和50 pmol/ml)检测不同组的Ckip-1 siRNA表达量,确定最佳的Ckip-1 siRNA组为50 pmol/ml;将大鼠模型分为模型组20只、生理盐水组20只、CKIP-1 siRNA组20只,向生理盐水组注射生理盐水,向CKIP-1 siRNA组注射CKIP-1 siRNA干预的骨髓间充质干细胞,空白组不做处置。检测注射后的实验鼠膝关节处成骨相关基因OPN、Runx2的mRNA的相对表达量,检测其成骨能力变化情况。结果 检测注射后的实验鼠膝关节处成骨相关基因OPN、Runx2的mRNA的相对表达量明显增加(P<0.05),检测其成骨能力增强(P<0.05)。结论 Ckip-1基因对骨髓间充质干细胞的负调控作用。CKIP-1 siRNA干预后骨髓间充质干细胞能够增加实验鼠膝关节处骨再生能力,为膝关节骨性关节炎的治疗提供新的方法,期望能够提出新的靶点。 展开更多
关键词 CKIP-1 siRNA 膝关节骨性关节炎 动物实验 机制进展
下载PDF
斑石鲷irf3基因鉴定及其在虹彩病毒感染下的表达模式
14
作者 李开敏 王磊 +5 位作者 巩志宏 王清滨 李华 杨桂文 黄友华 陈松林 《水产学报》 CAS CSCD 北大核心 2024年第4期346-357,共12页
干扰素调节因子(irf3)是干扰素调节因子(IRF)家族的一员,是I型干扰素依赖性免疫反应的主要转录调节因子,在针对DNA和RNA病毒的先天免疫反应中发挥重要作用。本研究中,斑石鲷irf3基因(Oplegnathus punctatus interferon regulatory facto... 干扰素调节因子(irf3)是干扰素调节因子(IRF)家族的一员,是I型干扰素依赖性免疫反应的主要转录调节因子,在针对DNA和RNA病毒的先天免疫反应中发挥重要作用。本研究中,斑石鲷irf3基因(Oplegnathus punctatus interferon regulatory factors 3,Opirf3)来自实验室斑石鲷基因组数据库,经分析鉴定Opirf3的CDS序列全长1362 bp,可编码453个氨基酸,预测其蛋白分子量为50.0 ku,理论等电点为4.97,有一个IRF结构域和一个IRF-3结构域。荧光定量分析结果显示,Opirf3在斑石鲷肝脏、鳃、心脏、皮肤、脾脏、肠、脑、肾脏、胃和头肾组织均有表达;虹彩病毒感染7 d时,免疫组织肝脏、脾脏和肾脏中Opirf3的表达水平显著上调。斑石鲷肾细胞系体外刺激实验显示,不同浓度poly I:C刺激后,Opirf3的表达量较对照组均显著升高,poly I:C浓度为100μg/mL时,肾脏细胞中Opirf3的相对表达水平升高,为对照组的86.8倍。siRNA干扰后,斑石鲷肾细胞系中Opirf3表达水平显著下调30%,下游基因IFN-α、CD40、CD80和IL-1β显著下调,IL-6显著上调。以上结果可能表明Opirf3基因参与了I型IFN在斑石鲷抗虹彩病毒过程中的先天免疫反应。本研究可为斑石鲷抗病分子育种提供理论依据。 展开更多
关键词 斑石鲷 irf3 基因表达 SIRNA
下载PDF
猪睾丸ACE启动子驱动的SPAG6 shRNA真核表达载体的构建
15
作者 张燕迪 顾涛涛 +2 位作者 任红艳 毕延震 方桂杰 《中国畜牧杂志》 CAS CSCD 北大核心 2024年第3期224-230,共7页
本文旨在研究猪睾丸ACE启动子驱动的SPAG6 shRNA在猪睾丸支持细胞(ST)中的干扰作用。利用PCR法从ST细胞基因组中扩增猪睾丸ACE启动子,构建重组质粒ACE-pIRES2-DsRed、ACE-pGL3-basic,通过红色荧光蛋白表达和双荧光素酶报告基因检测试验... 本文旨在研究猪睾丸ACE启动子驱动的SPAG6 shRNA在猪睾丸支持细胞(ST)中的干扰作用。利用PCR法从ST细胞基因组中扩增猪睾丸ACE启动子,构建重组质粒ACE-pIRES2-DsRed、ACE-pGL3-basic,通过红色荧光蛋白表达和双荧光素酶报告基因检测试验检测猪睾丸ACE启动子在ST细胞中的转录活性;根据SPAG6 mRNA靶序列设计合成3条siRNA序列,通过脂质体转染至ST细胞,利用实时荧光定量PCR及Western Blot检测siRNA的干扰效率;基于人miR-30a结构设计SPAG6 shRNA,构建重组载体ACE-sh-SPAG6-pcDNA3.1,Western Blot检测其对SPAG6的干扰效果。结果表明,成功构建重组质粒ACEpIRES2-DsRed、ACE-pGL3-basic,并证明猪睾丸ACE启动子在ST细胞中具有较强的转录活性;各试验组均能对靶基因SPAG6 mRNA的表达产生抑制作用,以siRNA-3的作用最佳。siRNA-3转染48 h后,SPAG6蛋白表达量显著下降(P<0.001),成功筛选出SPAG6基因的最佳干扰序列;成功构建重组质粒ACE-shSPAG6-pcDNA3.1,转染ST细胞48h后SPAG6蛋白表达量较阴性对照组显著下调(P<0.001)。本研究成功构建了猪睾丸ACE启动子驱动的SPAG6 shRNA真核表达载体,并在ST细胞中验证了其具有较好的干扰效果。 展开更多
关键词 SPAG6 ACE SIRNA SHRNA 基因表达
下载PDF
融合蛋白anti-EGFR-iRGD修饰的红细胞外囊泡联合siRNA靶向抑制三阴性乳腺癌恶性进程
16
作者 韦雪妮 杨忠慧 +2 位作者 黄吉 陈国梅 成昌娟 《现代肿瘤医学》 CAS 2024年第17期3197-3205,共9页
目的:通过红细胞来源的细胞外囊泡(red blood cell-derived extracellular vesicles,RBCEVs)构建靶向递送系统以提高对三阴性乳腺癌(triple-negative breast cancer,TNBC)恶性进程的抑制效率。方法:采用脂质插入法将融合蛋白anti-抗人... 目的:通过红细胞来源的细胞外囊泡(red blood cell-derived extracellular vesicles,RBCEVs)构建靶向递送系统以提高对三阴性乳腺癌(triple-negative breast cancer,TNBC)恶性进程的抑制效率。方法:采用脂质插入法将融合蛋白anti-抗人表皮生长因子受体(epidermal growth factor receptor,EGFR)-iRGD多肽结合至RBCEVs膜表面以构建生物相容性药物递送系统。通过电穿孔方式使连环蛋白β1(Catenin Beta 1,CTNNB1)-siRNA有效装载至anti-EGFR-iRGD-RBCEVs。进一步验证anti-EGFR-iRGD-si-CTNNB1-RBCEVs对TNBC增殖、迁移的影响及对上皮间充质转化相关蛋白表达的调控。结果:anti-EGFR-iRGD-si-CTNNB1-RBCEVs在120 h内具有较高血清稳定性,并且可有效防止RNA酶对CTNNB1-siRNA的降解。另外,该复合物可显著提高si-CTNNB1对TNBC细胞中CTNNB1基因及β-catenin蛋白的抑制作用并抑制TNBC细胞的增殖、迁移能力,下调Snail、Vimentin、N-cadherin并促进E-cadherin蛋白的表达。结论:该研究通过构建融合蛋白anti-EGFR-iRGD修饰的RBCEVs联合siRNA靶向抑制TNBC恶性进程,这将为治疗整合素α_(v)β_(3)高表达的TNBC提供更有利治疗方式。 展开更多
关键词 红细胞来源的细胞外囊泡 三阴性乳腺癌 SIRNA 上皮间充质转化 脂质插入法 连环蛋白β1
下载PDF
Antisense therapy:a potential breakthrough in the treatment of neurodegenerative diseases 被引量:1
17
作者 Roberta Romano Cecilia Bucci 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第5期1027-1035,共9页
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system.Currently,there is no cure for neurodegenerative diseases and th... Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system.Currently,there is no cure for neurodegenerative diseases and this means a heavy burden for patients and the health system worldwide.Therefore,it is necessary to find new therapeutic approaches,and antisense therapies offer this possibility,having the great advantage of not modifying cellular genome and potentially being safer.Many preclinical and clinical studies aim to test the safety and effectiveness of antisense therapies in the treatment of neurodegenerative diseases.The objective of this review is to summarize the recent advances in the development of these new technologies to treat the most common neurodegenerative diseases,with a focus on those antisense therapies that have already received the approval of the U.S.Food and Drug Administration. 展开更多
关键词 Alzheimer’s disease amyotrophic lateral sclerosis antisense oligonucleotide Huntington’s disease neurodegenerative disorders Parkinson’s disease SIRNA
下载PDF
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy 被引量:1
18
作者 Bao Li Haoran Niu +10 位作者 Xiaoyun Zhao Xiaoyu Huang Yu Ding Ke Dang Tianzhi Yang Yongfeng Chen Jizhuang Ma Xiaohong Liu Keda Zhang Huichao Xie Pingtian Ding 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2024年第2期170-187,共18页
Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target ... Anti-tumor angiogenesis therapy, targeting the suppression of blood vessel growth in tumors, presents a potent approach in the battle against cancer. Traditional therapies have primarily concentrated on single-target techniques, with a specific emphasis on targeting the vascular endothelial growth factor, but have not reached ideal therapeutic efficacy. In response to this issue, our study introduced a novel nanoparticle system known as CS-siRNA/PEITC&L-cRGD NPs. These chitosan-based nanoparticles have been recognized for their excellent biocompatibility and ability to deliver genes. To enhance their targeted delivery capability, they were combined with a cyclic RGD peptide (cRGD). Targeted co-delivery of gene and chemotherapeutic agents was achieved through the use of a negatively charged lipid shell and cRGD, which possesses high affinity for integrin αvβ3 overexpressed in tumor cells and neovasculature. In this multifaceted approach, co-delivery of VEGF siRNA and phenethyl isothiocyanate (PEITC) was employed to target both tumor vascular endothelial cells and tumor cells simultaneously. The co-delivery of VEGF siRNA and PEITC could achieve precise silencing of VEGF, inhibit the accumulation of HIF-1α under hypoxic conditions, and induce apoptosis in tumor cells. In summary, we have successfully developed a nanoparticle delivery platform that utilizes a dual mechanism of action of anti-tumor angiogenesis and pro-tumor apoptosis, which provides a robust and potent strategy for the delivery of anti-cancer therapeutics. 展开更多
关键词 ANTI-ANGIOGENESIS Tumor apoptosis Nanoparticles VEGF siRNA Hypoxia inducible factor(HIF)-1 protein Phenethyl isothi ocyanate(PEITC)
下载PDF
纳米凝胶搭载的siRNA通过靶向抑制施万细胞铁死亡促进周围神经损伤修复
19
作者 杨俊 黄欣林 +3 位作者 覃汉俊 谢思远 朱煜华 吴珺 《中国医学物理学杂志》 CSCD 2024年第4期495-503,共9页
目的:探究周围神经损伤(PNI)后施万细胞的死亡机制,使用纳米凝胶搭载的siRNA靶向抑制施万细胞死亡。方法:下载GEO数据库中PNI的转录组数据,依次进行数据处理、差异分析、GO功能富集分析、铁死亡通路鉴定以及靶基因的筛选。通过蛋白印记... 目的:探究周围神经损伤(PNI)后施万细胞的死亡机制,使用纳米凝胶搭载的siRNA靶向抑制施万细胞死亡。方法:下载GEO数据库中PNI的转录组数据,依次进行数据处理、差异分析、GO功能富集分析、铁死亡通路鉴定以及靶基因的筛选。通过蛋白印记和qPCR实验验证靶基因的差异性。自组装单宁酸(TA)-siRNA纳米凝胶,通过丁达尔效应实验、粒径和电位测量、细胞吞噬实验、细胞骨架染色和CCK-8细胞活力实验鉴定纳米凝胶的物理学和生物学特性。通过划痕实验、免疫荧光染色实验、蛋白印记和qPCR实验验证TA-siRNA纳米凝胶抑制施万细胞铁死亡的有效性。结果:PNI后施万细胞出现明显的铁死亡现象,Bex1是调控施万细胞铁死亡的关键基因。TA-siRNA纳米凝胶具有优良的物理学和生物学特性,能够将siRNA成功地携带到损伤的施万细胞中并沉默靶基因,从而有效地抑制施万细胞损伤后的铁死亡。结论:纳米凝胶搭载的siRNA可以靶向抑制施万细胞铁死亡,为临床治疗PNI提供新的方向。 展开更多
关键词 周围神经损伤 施万细胞 铁死亡 纳米凝胶 SIRNA 靶向治疗
下载PDF
Preparation and Characterization of pH-Responsive Charge Reversal Nanocomposite for miRNA Delivery
20
作者 余丹 YE Liyuan +2 位作者 LI Binbin MOU Fangzhi 殷义霞 《Journal of Wuhan University of Technology(Materials Science)》 SCIE EI CAS CSCD 2024年第4期1048-1052,共5页
pH-responsive charge reversal loaded miRNA nanocomposite was prepared by electrostatic self-assembly.The morphology,particle size and zeta potential of the nanocomposites were analyzed by transmission electron microsc... pH-responsive charge reversal loaded miRNA nanocomposite was prepared by electrostatic self-assembly.The morphology,particle size and zeta potential of the nanocomposites were analyzed by transmission electron microscopy and dynamic light scattering.The synthesis of the polymer was analyzed by^(1)H-NMR.The zeta-potential changes and cellular uptake effects of the nanocomplexes under different pH environments were investigated.The experimental results show that the surface morphology of the nanocomposite is spherical,and the average particle size is about 135 nm.As the pH value of the solution gradually decreases,the surface charge of the nanocomposite reverses from negative charge to positive charge(from-9.4 to+17.1 mV).Cellular uptake mediated by pH-responsive nanocomposite is selective for tumor cells,and the cellular uptake effect in tumor cells at pH 6.5 was approximately 3 times higher than that at pH 7.4.This pH responsive charge reversal nanocomposite has promising application prospects for gene delivery in the weak acid environment of tumors. 展开更多
关键词 charge conversion siRNA delivery pH responsive cancer therapy
下载PDF
上一页 1 2 129 下一页 到第
使用帮助 返回顶部